Comprehensive analysis of biomarker performance targeting "advanced fibrosis" and "at-risk" metabolic-dysfunction associated steatotic liver disease (MASH)-primary analysis of the LITMUS study cohort - Vali, Y; Wonders, K; Aithal, G; Aller, R; Allison, M; Arola, J; Banales, JM; Bernal, V; Berzigotti, A; Boursier, J; Brass, C; Bugianesi, E; et al. (Journal Of Hepatology, 2025)